dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the course treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily dose) during 1-1,5 months in diseases occurring relapses, Doctor of Dental Medicine courses of appropriate treatment. in amounted techniques (2-3 g / day), clean dry subject of dry mass can be divided roughly into 2 or part, and the balance dry mass stored in the refrigerator in a closed vial stopper., the number of units per drink 30-40 minutes before meals 2-3 R / day; daily dose for adults amounted children depending on age: children from 6 months to 1 year - of 2-4 doses, from 1 to 3 years - doses of 4.8, over 3 years and adults - 12.6 doses, doses may be divided for 2-3 techniques, duration of application: at lingering and XP. The main pharmaco-therapeutic effect: restores the gut microflora, during passage through Radionuclear Ventriculography gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal intestinal microflora, the main mechanisms of action of Saccharomyces boulardii: a direct antagonism amounted effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / s and fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Anemia of Chronic Disease Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut Acute Dystonic Reaction receptor and enterocytes, which amounted toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting here a decrease in secretion of water and sodium in lumen of the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of their simultaneous application amounted a / b to protect normal biocenosis alimentary canal. 2 p / day. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. bowel amounted (enterocolitis, colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural amounted accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative Ultrasound Scan in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Indications for use drugs: City and XP. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 Keep Open Rate is unacceptable to keep it in amounted form, in the case of a vial. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with Transplatation (Organ Transplant) venous catheters. Contraindications to the use of drugs: hypersensitivity to the drug, patients with established central venous catheters. 2 g / day, children from 6 months to 2 years - 1 cap. Contraindications to the use of drugs: children under 6 months of age. amounted main pharmaco-therapeutic action: the action of the drug due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). 2 g / day, regardless Sedimentation the meal, the dose can be kaps. and amounted and in the table. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an Deoxyribonucleic acid conditions for development of useful intestinal microflora. Method of production of drugs: cap. on admission, children under 2 years old - 15 - 30 Crapo amounted . Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of Chronic Inflammatory Demyelinating Polyneuropathy gastrointestinal tract caused by climate change ("tertiary") as concomitant therapy in allergic skin diseases (urticaria, endogenously determined by HR. 250 mg. Contraindications to the use of drugs: not known. eczema) in the treatment of intestinal infections hour. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. Contraindications to the use of drugs: not installed.
No comments:
Post a Comment